A minimal monitoring approach to hepatitis C treatment is safe and can help achieve a sustained virological response (SVR) rate that is comparable to the current standard of care, according to findings were presented at AASLD Liver Meeting Digital Experience. This minimal monitoring, or MINMON, study (NCT03512210), conducted by the AIDS Clinical Trials Group, aimed to evaluate a “Keep it Simple and Safe” Approach to treating hepatitis C.The study assessed the effectiveness of a minimal monitoring approach in resource-limited and lower-income countries as access to direct-acting antiviral therapies was being increased. The trial included people with hepatitis C who had not received any earlier treatment. These SVR rates are comparable to those seen in Phase III trials of hepatitis C treatment. “This is particularly relevant in the context of the COVID-19 pandemic as well as in low- and middle-income settings where on-treatment monitoring is a major barrier to treatment.”Click here to learn more about hepatitis C treatment.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.